Fredrick Frank

Fredrick Frank currently works at National Genetics Foundation, as Chairman, Evolution Life Science Partners, as Chairman, Puretech Health LLC, as Advisor, The New York Society of Security Analysts, Inc., as Member, The Journal of Life Sciences, as Member, and The Hotchkiss School, as Trustee-Emeritus.
Mr. Frank also formerly worked at Lehman Brothers, Inc., as Vice Chairman in 2008, EPIX Pharmaceuticals, Inc., as Chairman, Predix Pharmaceuticals, Inc., as Chairman, Peter J.
Solomon Co. LP, as Vice Chairman, Barclays Capital, Inc., as Vice Chairman from 1969 to 2009, Massachusetts Institute of Technology, as Chairman-Biomedical Innovation, Predix Pharmaceuticals Holdings, Inc., as Chairman from 2001 to 2006, The Irvington Institute for Immunological Research, as Chairman, Burrill Securities LLC, as Chairman, Applied Bioscience International, Inc., as Director from 1988 to 1996, Diagnostic Products Corp., as Director, Lifecore Biomedical, Inc., as Independent Director from 2011 to 2020, Pharmaceutical Product Development LLC, as Independent Director, The Salk Institute for Biological Studies, as Director, Institute for Systems Biology, as Director-Emeritus, PDL BioPharma, Inc., as Lead Independent Director from 2011 to 2012, Smith Barney & Co., Inc., as Director, Vice President & Co-Director-Research, The Life Sciences Foundation, as Director, HealthpointCapital LLC, as Board Advisor from 2010 to 2011, The National Center for Genome Resources, as Member-Governors Board, Chemical Processing Industry Analysts, as President, and Elm Street Advisors LLC, as Advisory Board Member.
Mr. Frank received his Masters Business Admin degree from Stanford University and undergraduate degree from Yale University.